ASPIRE trial for MM: updates from ASH 2017

The ongoing Phase III ASPIRE trial (NCT01080391) comparing carfilzomib, lenalidomide and dexamethasone (CRd) vs. lenalidomide and dexamethasone (Rd) in patients with relapsed multiple myeloma (MM) has... Author: VJHemOnc Added: 12/18/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts